Board meeting scheduled for May 19, 2026 to approve FY26 standalone and consolidated financial results.
Agenda includes reappointment of MD & CEO Kaustubha Basu and director Anita Lahiri for new terms.
Meeting will review legal proceedings against UCO Bank and DRT case status, and consider loan from subsidiary.
Board to approve annual reports, secretarial audit, and internal auditor appointment for FY2026-27.